ctrl K

Price Alert

Zevra Therapeutics Inc. (ZVRA)

NASDAQ: ZVRA · Real-Time Price · USD

9.51

0.23 (2.48%)

At close: Aug 21, 2025, 3:59 PM

9.62

1.16%

After-hours: Aug 21, 2025, 07:59 PM EDT

Zevra Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	33.78M	43.05M	65.47M	112.35M
Short-Term Investments	35.71M	24.69M	17.38M	n/a
Long-Term Investments	6.01M	n/a	20M	15.42M
Other Long-Term Assets	11.38M	9.94M	724K	438K
Receivables	10.51M	17.38M	8.3M	1.53M
Inventory	1.97M	24.08M	n/a	n/a
Other Current Assets	3.02M	-23.43M	189K	252K
Total Current Assets	86.03M	86.94M	93.02M	115.06M
Property-Plant & Equipment	1.01M	1.53M	1.78M	2.02M
Goodwill & Intangibles	73.69M	73.93M	n/a	n/a
Total Long-Term Assets	92.1M	85.39M	22.51M	17.89M
Total Assets	178.13M	172.33M	115.53M	132.94M
Account Payables	13.07M	13.99M	3.61M	516K
Deferred Revenue	n/a	n/a	4.66M	2.52M
Short-Term Debt	n/a	37.7M	486K	371K
Other Current Liabilities	3.2M	10.82M	233K	-604K
Total Current Liabilities	34.06M	73.72M	12.02M	4.23M
Long-Term Debt	59.5M	5.07M	12.8M	n/a
Other Long-Term Liabilities	44.52M	31.22M	14.55M	355K
Total Long-Term Liabilities	104.4M	36.74M	28.2M	1.59M
Total Liabilities	138.46M	110.46M	40.22M	5.82M
Total Debt	60.3M	43.77M	14.12M	1.61M
Common Stock	5K	4K	3K	4K
Retained Earnings	-505.29M	-399.78M	-353.73M	-267.03M
Comprehensive Income	631K	-43K	113K	n/a
Shareholders Equity	39.67M	61.86M	75.12M	127.12M
Total Investments	41.72M	24.69M	37.38M	15.42M